A large open-label study of venlafaxine in depressed outpatients by community-based physicians
by
Joffe RT, Marshall AM, Lee DK
Department of Psychiatry,
McMaster University, Hamilton, Ontario, Canada.
J Clin Psychiatry 1998 Oct; 59(10):515-20


ABSTRACT

BACKGROUND: Studies to date suggest that venlafaxine is effective, well tolerated, and safe in a broad spectrum of patients. We examined the clinical utility and tolerability of venlafaxine in patients treated by community-based psychiatrists and family physicians in a naturalistic clinical setting. METHOD: Nineteen physicians each recruited 10 to 20 physicians to enroll 5 patients each maximum, diagnosed with DSM-IV major depression or dysthymia. The patients were at least moderately ill (Clinical Global Impressions) with a score of at least 32 on the Zung Self-Rating Depression Scale. After baseline clinical and laboratory assessments, each patient received 37.5 mg of venlafaxine b.i.d., with adjustments possible at the 5 visits during the next 8 weeks. RESULTS: Of the 880 patients at baseline, 682 completed the 8-week study. The daily doses of venlafaxine ranged between 18.75 mg and 375 mg, with 80% receiving between 75 and 150 mg/day by 8 weeks. The intent-to-treat analysis revealed that at 8 weeks, 62% (522 of 843) of patients were either much or very much improved. Nausea was the most frequent side effect, followed by somnolence, headache, and dry mouth. CONCLUSION: Venlafaxine has good clinical utility and tolerability in a community-based sample of a broad spectrum of depressed outpatients.
SSRIs
NARIs
Depression
Venlafaxine compared
Venlafaxine v fluoxetine
Venlafaxine pharmacology
Venlafaxine for dysthymia
Venlafaxine for depression
Venlafaxine plus bupropion
Venlafaxine: pharmacokinetics etc
Venlafaxine for depressive cocaine users
Venlafaxine for treatment-resistant depression
Venlafaxine (Effexor) analgesia and the opioid system
Depression treated with different formulations of venlafaxine
February 2008: FDA licenses antidepressant desvenlafaxine (Pristiq)


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family